Masaki Hanibuchi

2.7k total citations · 1 hit paper
105 papers, 1.9k citations indexed

About

Masaki Hanibuchi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Masaki Hanibuchi has authored 105 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Pulmonary and Respiratory Medicine, 49 papers in Oncology and 25 papers in Molecular Biology. Recurrent topics in Masaki Hanibuchi's work include Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (19 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers). Masaki Hanibuchi is often cited by papers focused on Lung Cancer Treatments and Mutations (24 papers), Lung Cancer Research Studies (19 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers). Masaki Hanibuchi collaborates with scholars based in Japan, United States and United Kingdom. Masaki Hanibuchi's co-authors include Yasuhiko Nishioka, Saburo Sone, Seiji Yano, Soji Kakiuchi, Hisanori Uehara, Hirokazu Ogino, Hisatsugu Goto, Wei Wang, Toyokazu Miki and Qi Li and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Masaki Hanibuchi

96 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

2008 513 citations Seiji Yano, Wei Wang et al. Cancer Research profile →

Peers

Countries citing papers authored by Masaki Hanibuchi

Since Specialization

Citations

This map shows the geographic impact of Masaki Hanibuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Hanibuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Hanibuchi more than expected).

Fields of papers citing papers by Masaki Hanibuchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaki Hanibuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Hanibuchi. The network helps show where Masaki Hanibuchi may publish in the future.

Co-authorship network of co-authors of Masaki Hanibuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Masaki Hanibuchi. A scholar is included among the top collaborators of Masaki Hanibuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaki Hanibuchi. Masaki Hanibuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Serial Changes of Fractional Exhaled Nitric Oxide and Periostin in the Treatment Course of Cough Variant Asthma 2025 ·American Journal of Respiratory and Critical Care Medicine ·Yoshikazu Isomura, Masaki Hanibuchi, Seidai Sato, Atsushi Mitsuhashi, Tetsuya Kajimoto, Atsuro Saijo, Yasuhiko Nishioka	0
2	A favorable antitumor efficacy of sotorasib in a patient with KRAS G12C-mutated pulmonary large-cell neuroendocrine carcinoma 2025 ·International Cancer Conference Journal ·Keisuke Nakanishi, Hirokazu Ogino, (unknown), (unknown), (unknown), (unknown), Yutaka Morita, (unknown), (unknown), (unknown), Noriko Bando, Atsushi Mitsuhashi, Seidai Sato, Masaki Hanibuchi, Yasuhiko Nishioka	0
3	A case of pleural mesothelioma with immunohistochemical staining positive for Krebs von den Lungen-6 2024 ·Respiratory Medicine Case Reports ·(unknown), Seidai Sato, (unknown), Takeshi Masuda, (unknown), Hirokazu Ogino, Hirohisa Ogawa, Masaki Hanibuchi, Noboru Hattori, Yasuhiko Nishioka	0
4	A multicenter, open‐label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non‐small cell lung cancer 2023 ·Thoracic Cancer ·(unknown), Masaki Hanibuchi, Eiji Takeuchi, Takashi Haku, Takanori Kanematsu, Naoki Nishimura, Yuko Toyoda, Atsushi Mitsuhashi, Kenji Otsuka, Seidai Sato, Hisatsugu Goto, (unknown), Hirokazu Ogino, Hiroshi Nokihara, Tsutomu Shinohara, Yasuhiko Nishioka	2
5	Identification of fibrocyte cluster in tumors reveals the role in antitumor immunity by PD-L1 blockade 2023 ·Cell Reports ·Atsushi Mitsuhashi, Kazuya Koyama, Hirokazu Ogino, (unknown), (unknown), (unknown), Kenji Otsuka, Masamichi Sugimoto, Osamu Kondoh, Hiroshi Nokihara, Masaki Hanibuchi, Hiromitsu Takizawa, Tsutomu Shinohara, Yasuhiko Nishioka	12
6	Antipodoplanin antibody enhances the antitumor effects of CTLA‐4 blockade against malignant mesothelioma by natural killer cells 2023 ·Cancer Science ·(unknown), Atsushi Mitsuhashi, (unknown), Hirokazu Ogino, (unknown), (unknown), Hiroshi Nokihara, Seidai Sato, Tsutomu Shinohara, Masaki Hanibuchi, Shinji Abe, Mika K. Kaneko, Yukinari Kato, Yasuhiko Nishioka	3
7	The clinical features of older patients with lung cancer in comparison with their younger counterparts 2018 ·Respiratory Investigation ·Hirokazu Ogino, Masaki Hanibuchi, Satoshi Sakaguchi, Yuko Toyoda, (unknown), Hiroshi Kawano, Soji Kakiuchi, Kenji Otsuka, Atsuro Saijo, Masahiko Azuma, Hiroshi Nokihara, Hisatsugu Goto, Yasuhiko Nishioka	4
8	Dll4-Fc, an Inhibitor of Dll4-Notch Signaling, Suppresses Liver Metastasis of Small Cell Lung Cancer Cells through the Downregulation of the NF-κB Activity 2012 ·Molecular Cancer Therapeutics ·Takuya Kuramoto, Hisatsugu Goto, Atsushi Mitsuhashi, Sho Tabata, Hirohisa Ogawa, Hisanori Uehara, Atsuro Saijo, Soji Kakiuchi, Yoichi Maekawa, Koji Yasutomo, Masaki Hanibuchi, Shin-ichi Akiyama, Saburo Sone, Yasuhiko Nishioka	41
9	SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model 2012 ·Respirology ·(unknown), Masaki Hanibuchi, Hisatsugu Goto, Takuya Kuramoto, (unknown), Soji Kakiuchi, Seidai Sato, Satoshi Sakaguchi, (unknown), Yasuhiko Nishioka, Shin‐ichi Akiyama, Saburo Sone	11
10	E7080 Suppresses Hematogenous Multiple Organ Metastases of Lung Cancer Cells with Nonmutated Epidermal Growth Factor Receptor 2011 ·Molecular Cancer Therapeutics ·Hirokazu Ogino, Masaki Hanibuchi, Soji Kakiuchi, (unknown), Hisatsugu Goto, Kenji Ikuta, Tadaaki Yamada, Hisanori Uehara, Akihiko Tsuruoka, Toshimitsu Uenaka, Wei Wang, Qi Li, Shinji Takeuchi, Seiji Yano, Yasuhiko Nishioka, Saburo Sone	16
11	Gender difference in bone metastasis of human small cell lung cancer, SBC-5 cells in natural killer-cell depleted severe combined immunodeficient mice 2010 ·Clinical & Experimental Metastasis ·Satoshi Sakaguchi, Hisatsugu Goto, Masaki Hanibuchi, (unknown), Hirokazu Ogino, Soji Kakiuchi, Hisanori Uehara, Seiji Yano, Yasuhiko Nishioka, Saburo Sone	9
12	Novel dual targeting strategy with vandetanib induces tumor cell apoptosis and inhibits angiogenesis in malignant pleural mesothelioma cells expressing RET oncogenic rearrangement 2009 ·Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) ·Hirokazu Ogino, Seiji Yano, Soji Kakiuchi, Tadaaki Yamada, Kenji Ikuta, Emiko Nakataki, Hisatsugu Goto, Masaki Hanibuchi, Yasuhiko Nishioka, Anderson J. Ryan, Saburo Sone	17
13	Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations breakdown → 2008 ·Cancer Research ·Seiji Yano, Wei Wang, Qi Li, Kunio Matsumoto, (unknown), Takahiro Nakamura, Hirokazu Ogino, Soji Kakiuchi, Masaki Hanibuchi, Yasuhiko Nishioka, Hisanori Uehara, Tetsuya Mitsudomi, Yasushi Yatabe, Toshikazu Nakamura, Saburo Sone	513
14	Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells 2008 ·Lung Cancer ·Wei Wang, Yasuhiko Nishioka, Shuji Ozaki, Ali Jalili, Vinod Kumar Verma, Masaki Hanibuchi, Shinji Abe, Kazuo Minakuchi, Toshio Matsumoto, Saburo Sone	16
15	[Differences in the therapeutic strategies for lung cancer between Europe/United States and Japan]. 2007 ·PubMed ·Masaki Hanibuchi, Seiji Yano, (unknown), Saburo Sone	1
16	Clinical Examination of Acute Exacerbation of Idiopathic Interstitial Pneumonia (IIP) Combined With Lung Cancer After Anti-cancer Treatment. 2001 ·Haigan ·Masaki Hanibuchi, Toshihiko Yamaguchi, Tatsuya Okada, Masaru Nakagawa, Soichiro Yokota, Masami Ito, (unknown)	17
17	A New Quinoline Derivative MS‐209 Reverses Multidrug Resistance and Inhibits Multiorgan Metastases by P‐glycoprotein‐expressing Human Small Cell Lung Cancer Cells 2001 ·Japanese Journal of Cancer Research ·Hiroshi Nokihara, Seiji Yano, Yasuhiko Nishioka, Masaki Hanibuchi, (unknown), Takashi Tsuruo, Saburo Sone	9
18	Augmentation by interleukin-18 of MHC-nonrestricted killer activity of human peripheral blood mononuclear cells in response to interleukin-12 2000 ·International Journal of Immunopharmacology ·Sukh Mahendra Singh, Hiroaki Yanagawa, Masaki Hanibuchi, Toyokazu Miki, Haruki Okamura, Saburo Sone	16
19	Immunological circumvention of multiple organ metastases of multidrug resistant human small cell lung cancer cells by mouse-human chimeric anti-ganglioside GM2 antibody KM966 2000 ·Clinical & Experimental Metastasis ·Masaki Hanibuchi, Seiji Yano, Yasuhiko Nishioka, Hiroaki Yanagawa, Toyokazu Miki, Saburo Sone	5
20	Combined therapy with anti-p-glycoprotein antibody and macrophage colony-stimulating factor gene transduction for multiorgan metastases of multidrug-resistant human small cell lung cancer in nk cell-depleted scid mice 1999 ·International Journal of Cancer ·Seiji Yano, Masaki Hanibuchi, Yasuhiko Nishioka, Hiroshi Nokihara, Naoki Nishimura, Takashi Tsuruo, Saburo Sone	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact